2nd Annual Forum for Payors -- Advances in Genomics and Personalized Medicine
Evaluate Clinical Utility and Cost-Effectiveness of Molecular Diagnostic Testing
Mar. 24-25, 2010
8:15 Making Partnerships Work in this New Era of U.S. and Global Healthcare Reform
Healthcare reform in the coming years will mean far more than the health insurance reform now being finalized by the Congress and the Obama Administration. It will involve different types and levels of reforms, including FDA, personalized-medicine, medical-home and healthcare-globalization. Embracing and then traversing these new and highly complex landscapes, first successfully and then profitably, will require innovations in science, communications and behavior modification, as well as the creation of new kinds and levels of effective business partnerships.
Understand healthcare reform now and what it will look like three years from now
Learn what key roles reform in the FDA, personalized medicine, medical home and healthcare globalization will play
Understand how to incorporate your partners’ and customers’ perspectives into your sales force effectiveness (SFE) strategies to engage more effectively with them
Define scientific imperatives associated with personalized medicine through a case study review and how policy decisions and evolving partnerships can affect them, both positively and negatively
John A. Norris, JD, MBA, Former Chief Operating Officer, FDA; Chief Operating Officer, Health Discovery Corporation
Stephen Barnhill, M.D., Chairman and Chief Executive Officer, Health Discovery Corporation
